TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News

Coronavirus
3 Top Canadian Stocks to Buy Right Now for Stellar Returns

Cannabis Stocks
Bullet Dodged: 2 High-Profile Stocks That Tanked This Year

Tech Stocks
Buy These 4 Canadian Stocks for Superior Returns in 2021

Cannabis Stocks
Pot Stocks: With Profitability on the Way, Is Cannabis Worth an Investment?

Cannabis Stocks
2 Canadian Stocks That Could See Explosive Growth in 2021

Cannabis Stocks
3 Weed Stocks That Have Seen Dizzying 155% Gains

Cannabis Stocks
The Best Cannabis Stocks to Buy Before U.S. Legalization

Investing
1 Weed Stock Company That Lost Over $800 Million in 3 Months

Tech Stocks
3 Canadian Stocks to Buy After Their Impressive Quarterly Earnings

Cannabis Stocks
Has the Cannabis Bubble 2.0 Popped?

Cannabis Stocks
Canopy Growth (TSX:WEED) Jumps 20%: But Should You Buy?
